Literature DB >> 3599911

Cyclosporin A stimulates hair growth in nude mice.

M Sawada, N Terada, H Taniguchi, R Tateishi, Y Mori.   

Abstract

When cyclosporin A (CyA) at doses of 10 and 100 mg/kg body weight/day was given for 14 days to six-week-old female and male nude mice, the length of the hair of CyA-treated mice began to increase from day 7 of the treatment at both doses. There was no hair growth in the control mice, which were given only olive oil. The hair length of CyA-treated mice was 3 to 4 times longer than that of control mice. CyA at both doses induced hair growth to the same extent. There was no difference in the hair growth between the male and female mice. The growth of hair was apparent on the neck, back, and hip. However, no hair growth was observed in the abdominal region. The hair length of the CyA-treated mice decreased after cessation of the treatment, and returned to the level of the control mice on day 14 after the end of the treatment. Microscopic examination revealed that there was no difference in the number of hair follicles between the control and the CyA treated mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3599911

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  13 in total

1.  NFATc1 balances quiescence and proliferation of skin stem cells.

Authors:  Valerie Horsley; Antonios O Aliprantis; Lisa Polak; Laurie H Glimcher; Elaine Fuchs
Journal:  Cell       Date:  2008-01-25       Impact factor: 41.582

2.  The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results.

Authors:  Jing Sun; Kathleen A Silva; Kevin J McElwee; Lloyd E King; John P Sundberg
Journal:  Exp Dermatol       Date:  2008-10       Impact factor: 3.960

Review 3.  A new role for an old friend: NFAT and stem cell quiescence.

Authors:  Anthony E Oro
Journal:  Cell Stem Cell       Date:  2008-02-07       Impact factor: 24.633

4.  Histological and ultrastructural effects of cyclosporin A on normal human skin xenografted on to nude mice.

Authors:  J Kanitakis; A Ramirez-Bosca; M Haftek; J Thivolet
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation.

Authors:  M P Santini; C Talora; T Seki; L Bolgan; G P Dotto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

6.  Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.

Authors:  K J Tracey; S Morgello; B Koplin; T J Fahey; J Fox; A Aledo; K R Manogue; A Cerami
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

7.  Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Normalization of the nu/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia.

Authors:  D M Danilenko; B D Ring; D Yanagihara; W Benson; B Wiemann; C O Starnes; G F Pierce
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

8.  Downregulation of NFAT2 promotes melanogenesis in B16 melanoma cells.

Authors:  Young Sook Lee; Dong Woon Kim; Sooil Kim; Hye In Choi; Young Lee; Chang Deok Kim; Jeung Hoon Lee; Sang Do Lee; Young Ho Lee
Journal:  Anat Cell Biol       Date:  2010-12-31

Review 9.  The psoriatic epidermal lesion and anagen hair growth may share the same "switch-on" mechanism.

Authors:  R Paus; R E Link
Journal:  Yale J Biol Med       Date:  1988 Sep-Oct

Review 10.  Proliferative and non-proliferative lesions of the rat and mouse integument.

Authors:  Lars Mecklenburg; Donna Kusewitt; Carine Kolly; Silke Treumann; E Terence Adams; Kelly Diegel; Jyoji Yamate; Wolfgang Kaufmann; Susanne Müller; Dimitry Danilenko; Alys Bradley
Journal:  J Toxicol Pathol       Date:  2013       Impact factor: 1.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.